Omnipaque 240mg/mL PF recall: Sterility Concern
Omnipaque 240mg/mL PF, 300mg/mL PF, in 3 mL, 5 mL, and 10 mL, vials, manufactured by New England Compounding Center, Framingham, MA
Why was Omnipaque 240mg/mL PF recalled?
Lack of Assurance of Sterility
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
All lot codes
- Product
- Omnipaque 240mg/mL PF, 300mg/mL PF, in 3 mL, 5 mL, and 10 mL, vials, manufactured by New England Compounding Center, Framingham, MA
- Recalling firm
- New England Compounding Center
- Quantity
- 8919 vials
- Distribution
- Nationwide
- Recall date
- January 9, 2013
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)